Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 47.9B | 47.1B | 47.4B | 49.2B |
| Cost of revenue | 33.9B | 33.1B | 34.8B | 35.1B |
| Gross profit | 14.0B | 14.1B | 12.6B | 14.1B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 7.6B | 7.5B | 7.8B | 7.8B |
| Operating income | 6.4B | 6.6B | 4.8B | 6.3B |
| Non operating interest income | ||||
| Income | 290M | 449M | 457M | 408M |
| Expense | 725M | 786M | 797M | 725M |
| Other income expense | 619M | 562M | 4M | 379M |
| Pretax income | 6.7B | 6.9B | 4.5B | 6.6B |
| Tax provision | 2.7B | 2.9B | 2.2B | 2.7B |
| Net income | 3.9B | 4.0B | 2.4B | 3.8B |
| Basic EPS | — | 1.7 | 1.0 | 1.6 |
| Diluted EPS | — | 1.7 | 1.0 | 1.6 |
| Basic average shares | — | 2.3B | 2.4B | 2.4B |
| Diluted average shares | — | 2.3B | 2.4B | 2.4B |
| EBITDA | 10.5B | 10.7B | 9.4B | 10.4B |
| Net income from continuing op. | 3.9B | 4.0B | 2.4B | 3.8B |
| Minority interests | -70M | -63M | -67M | -60M |
| Preferred stock dividends | — | — | — | — |